A real-world study on Senaparib for first-line maintenance treatment in patients with newly diagnosed advanced ovarian cancer,fallopian tube cancer,or primary peritoneal cancer

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 52703e7fd21563db62f2b371f3679a2bfac65b77
First added on: Sep 12, 2026